Suppr超能文献

研究慢性给予某些抗高血压药物对大鼠卵巢组织中酶和非酶氧化应激/抗氧化参数的影响。

Investigation of the effects of the chronic administration of some antihypertensive drugs on enzymatic and non-enzymatic oxidant/antioxidant parameters in rat ovarian tissue.

机构信息

Ministry of Health, Obstetrics and Gynecology Hospital, Iğdır, Turkey.

出版信息

Gynecol Endocrinol. 2011 Nov;27(11):895-9. doi: 10.3109/09513590.2010.551564. Epub 2011 Jan 28.

Abstract

OBJECTIVE

In this study, effects of chronic antihypertensive drug (clonidine, methyldopa, amlodipine, ramipril, and rilmenidine) treatment on antioxidant-oxidant parameters were investigated in rat ovarian tissue.

STUDY DESIGN

Chronic drug administration for 30 days and at the end, biochemical examinations (total glutathione (tGSH), glutathione peroxidase (GPO), glutathione reductase (GR), glutathione s-transferase (GST), superoxide dismutase (SOD), nitric oxide (NO), catalase (CAT), malondialdehyde (MDA), and myeloperoxidase (MPO) analyses) were performed.

RESULTS

The levels of glutathione (GSH) and NO, and the activities of GPO, GR, GST, SOD, and CAT were measured the lowest in ramiprile group. Also in ramiprile group, the level of MDA and the activity of MPO was the highest.

CONCLUSION

We divided the drugs into four groups according to their biochemical side effect potentials in ovarian tissue: (I) Drugs which have no clear negative effect on ovarian tissue: clonidine, rilmenidine; (II) Drugs which have mild negative effect on ovarian tissue: methyldopa; (III) Drugs which have moderate negative effect on ovarian tissue: amlodipine; (IV) Drugs which have severe negative effect on ovarian tissue: ramipril. These data might be useful in the selection of the least toxic antihypertensive drug in pregnant and/or normal females.

摘要

目的

本研究旨在探讨长期应用抗高血压药物(可乐定、甲基多巴、氨氯地平、雷米普利和利美尼定)对大鼠卵巢组织抗氧化-氧化参数的影响。

研究设计

对大鼠进行为期 30 天的慢性药物给药,然后进行生化检查(总谷胱甘肽(tGSH)、谷胱甘肽过氧化物酶(GPO)、谷胱甘肽还原酶(GR)、谷胱甘肽 S-转移酶(GST)、超氧化物歧化酶(SOD)、一氧化氮(NO)、过氧化氢酶(CAT)、丙二醛(MDA)和髓过氧化物酶(MPO)分析)。

结果

雷米普利组的谷胱甘肽(GSH)和 NO 水平以及 GPO、GR、GST、SOD 和 CAT 的活性最低。此外,雷米普利组 MDA 水平和 MPO 活性最高。

结论

我们根据这些药物在卵巢组织中的生化副作用潜在风险将其分为四组:(I)对卵巢组织无明显不良影响的药物:可乐定、利美尼定;(II)对卵巢组织仅有轻微不良影响的药物:甲基多巴;(III)对卵巢组织有中度不良影响的药物:氨氯地平;(IV)对卵巢组织有严重不良影响的药物:雷米普利。这些数据可能有助于选择对妊娠和/或正常女性毒性最小的降压药物。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验